- Home
- NTRB vs DERM Comparison
NTRB vs DERM Comparison
Compare NTRB & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTRB
- DERM
- Stock Information
- Founded
- NTRB 2016
- DERM 2014
- Country
- NTRB United States
- DERM United States
- Employees
- NTRB N/A
- DERM N/A
- Industry
- NTRB Industrial Specialties
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- NTRB Health Care
- DERM Health Care
- Exchange
- NTRB Nasdaq
- DERM Nasdaq
- Market Cap
- NTRB 84.1M
- DERM 95.0M
- IPO Year
- NTRB N/A
- DERM 2021
- Fundamental
- Price
- NTRB $7.46
- DERM $5.19
- Analyst Decision
- NTRB Buy
- DERM Strong Buy
- Analyst Count
- NTRB 1
- DERM 3
- Target Price
- NTRB $13.00
- DERM $9.50
- AVG Volume (30 Days)
- NTRB 216.4K
- DERM 55.0K
- Earning Date
- NTRB 12-04-2024
- DERM 03-20-2025
- Dividend Yield
- NTRB N/A
- DERM N/A
- EPS Growth
- NTRB N/A
- DERM N/A
- EPS
- NTRB N/A
- DERM N/A
- Revenue
- NTRB $2,021,771.00
- DERM $57,771,000.00
- Revenue This Year
- NTRB $7.95
- DERM N/A
- Revenue Next Year
- NTRB $538.25
- DERM $36.49
- P/E Ratio
- NTRB N/A
- DERM N/A
- Revenue Growth
- NTRB N/A
- DERM N/A
- 52 Week Low
- NTRB $2.22
- DERM $2.85
- 52 Week High
- NTRB $11.78
- DERM $6.89
- Technical
- Relative Strength Index (RSI)
- NTRB 55.21
- DERM 60.26
- Support Level
- NTRB $6.68
- DERM $4.85
- Resistance Level
- NTRB $8.24
- DERM $5.37
- Average True Range (ATR)
- NTRB 0.74
- DERM 0.40
- MACD
- NTRB -0.11
- DERM 0.02
- Stochastic Oscillator
- NTRB 43.32
- DERM 70.49
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.